ABSTRACT
The COVID-19 pandemic has been devastating to all human endeavors, and scientific research has not been spared. We queried how the retraction of publications might have been affected during the pandemic years 2020–2021. Searches performed with Retraction Watch Database (RWD) revealed that the total number of retractions (as proxied by retraction-related notices) rose steadily from 2013 into the pandemic years 2020–2021. Interestingly, while retractions in the physical and social sciences tapered during 2020–2021, those of the basic life sciences and health sciences showed robust increases in 2020, with the former maintaining a steep rise in 2021. This rise in retractions belied a tapering of total relevant publications in the same year and is confirmed with a complementary search strategy in Scopus. The retraction rate in the medical sciences, particularly those relating to infectious disease, is clearly affected by the anomalous high retraction rate of COVID-19-related papers. However, the sustained increase in the retraction rate of the basic life sciences papers, could be due, at least partly, to retraction spikes in several journals. The rise in retractions in the life and medical sciences could be attributed to heightened post-publication peer review of papers in online platforms such as PubPeer, where numerous problematic papers have been revealed.
ABSTRACT
The ongoing Coronavirus Disease 2019 (COVID-19) global pandemic has triggered a flurry of associated research publications, numbering to ~137 papers a day since February 2020. This rate of publication appears to be exceptionally high, when compared to research papers published on other similar topics. Searches of COVID-19-associated publications on PubMed and Retraction Watch Database indicate that the retraction record appearance rate for COVID-19-related research is also exceptionally high compared to other related research topics in viral epidemics/pandemics and surpasses the basal level of about 4 in 10,000 papers. This finding serves as a reminder and caution against any lapses in the standard of work, peer review, and publication of COVID-19-related research.